Climedo logo — The leading European EDC for eCOA-focused post-approval tria...

Climedo

The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization.

Founded 2017 Germany Germany 29 employees Seed Total: $6.18M Health Care, Pharmaceutical

General Information

Company Name Climedo
Founded Year 2017
Location Germany Germany +1
Employees 29
Industries Health Care, Pharmaceutical
Funding Stage Seed

Get notified when Climedo moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Climedo

Climedo is a Munich-based startup, founded in 2017, that offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. The company's patient-centric approach and real-time data insights empower clients in the Health Care and Pharmaceutical industries to better engage with healthcare professionals and key opinion leaders (KOLs). With over 1.7 million patients enrolled to date, Climedo has positioned itself as a trusted partner for pharma, medtech, CROs, and academia. In its last investment round on 16 February 2022, Climedo secured a €5.00M Seed Round investment from Nauta Capital, WestTech Ventures, and Prof. Dr. med. Christian Wallwiener. The company's slogan, "The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization," underscores its focus on streamlining post-approval trials and accelerating the commercialization of medical innovations to reach more patients faster.

Taxonomy: eCOA, EDC, Real-world evidence, Medical Research, Clinical Validation, Digital Healthcare, Pharma, BioTech, MedTech, Commercialization, Market Access, KOL engagement, Post-approval studies, Data reporting

Services & Products

eClinical platform
Real-World Evidence
Clinical Data Management

Target Customers

Pharmaceutical & Biotech companies MedTech companies Clinical Research Organizations Hospitals Research Institutes

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor
•••• ••••
16 Feb 2022
Pre Seed Round •••••• 1
Investor
27 May 2019
Grant •••••• 1 •••• •••• 01 Nov 2017
Grant •••••• - 01 Mar 2017

Climedo Alternatives & Competitors

Climedo vs
openDoctor
openDoctor United States

Healthcare scheduling on autopilot. Patient engagement. Real-time. Online.

Seed
33 employees
Computing, Digital Health
Climedo vs

Confidence Locks because Confidence Rocks!

1 employees
Climedo vs

The platform for real patient connections.

Seed
12 employees
Health Care
Also compare with: Climedo vs uMotif uMotif

FAQ About Climedo

The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization.
Climedo was founded in 2017.
Climedo is headquartered in Germany.
Climedo operates in the following industries: Health Care, Pharmaceutical.
Climedo has approximately 29 employees.
Climedo has completed 4 funding rounds, raising a total of $6.18M. The latest funding stage is Seed.
Climedo offers: eClinical platform, Real-World Evidence, Clinical Data Management.
Top alternatives and competitors to Climedo include openDoctor, REAL FRINGE HAIR BANDS - CONFIDENT LOCKS, VidasPrime, uMotif, blockit. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Climedo and openDoctor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Climedo and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes